Altered composition of high density lipoproteins in women with the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3389-3394

  Rajkhowa, M ^a,b   Neary, R H ^a   Kumpatla, P ^a   Game, F L ^a   Jones, P W ^a   Obhrai, M S ^a   Clayton, R N ^a  

^a Central Pathology Laboratory   (United Kingdom)

^b Cmw Universities Train Fellowship

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANDROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; POLYCYSTIC OVARY SYNDROME;

EID: 0030952583     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.10.3389     Document Type: Article

References (37)

1. Futterweit W, Mechanick JI. 1988 Polycystic ovarian disease: etiology, diagnosis, and treatment. Compr Ther. 14:12-20.
2. Bush TL, Fried LP, Barret-Connor E. 1988 Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem. 34:B60-B70.
3. Dahigren E, Janson PO, Johansson S, et al. 1992 Polycystic ovary syndrome and risk for myocardial infarction. Acta Obstet Gynaecol Scand. 71:599-604.
4. Pyorola K. 1979 Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 2:131-141.
5. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Clauda JR, Rosselin G. 1980 Relationship of plasma insulin levels to the incidence of myocardial and coronary heart disease mortality in a middle aged population. Diabetologica. 19:205-210.
6. Zavaroni I, Bonora E, Pagliara M, et al. 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinaemia and normal glucose tolerance. N Engl J Med. 320:702-706.
7. Bengtsson C, Bjorkelund C, Lapidus L, Lissner L. 1993 Association of serum lipid concentration and obesity with mortality in women. Twenty year follow up of participants in prospective population study in Gothenberg, Sweden. Br Med J. 307:1385-1388.
8. Talbott E, Guzick D, Clerici A, et al. 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 15:821-826.
9. Conway GS, Agrawal R, Betterridge DJ, et al. 1992 Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 37:119-125.
10. Dahlgren E, Johansson S, Lindstedt G, et al. 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow up focussing on natural history and circulating hormones. Fertil Steril. 57:505-513.
11. Blass KM, Newschaffer CJ, Klag MJ, Bush TL. 1993 Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 153:2209-2216.
12. Adams J, Polson DW, Franks S. 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 293:355-359.
13. Rajkhowa M, Bicknell J, Jones M, Clayton RN. 1994 Insulin sensitivity in obese and nonobese women with polycystic ovary syndrome-relationship to hyperandrogenaemia. Fertil Steril. 61:605-611.
14. Nanjee MN, Wheeler MJ. 1985 Plasma free testosterone-is an index sufficient? Ann Clin Biochem. 22:387-390.
15. Trinder P, Webster D. 1984 Determination of HDL-cholesterol using 2,3,4-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem. 21:430-433.
16. Anderson KM, Wilson PW, Odell PM, Kannel WB. 1991 An updated coronary risk profile. Circulation. 83:356-362.
17. Wild RA, Painter PC, Coulson PB, et al. 1985 Lipoprotein lipid concentrations and cardiovasular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 61:946-951.
18. Wild RA, Bartholomew M. 1988 The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am J Obstet Gynecol. 159:423-427.
19. Wild RA, Aplebaum-Bowden D, Demers LM. 1990 Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 36:283-289.
20. Simard G, Perret B, Durand S, Collet X, Chap H, Douste-Blazy L. 1989 Phosphotidylcholine and triglycerol hydrolysis in HDL as induced by hepatic lipase: modulation of the phospholipase activity by changes in the particle surface or in the lipid core. Biochim Biophys Acta. 1001:225-233.
21. Dullart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. 1994 Effect of adiposity on lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest. 24:188-194.
22. Baynes C, Henderson AD, Anyaoku V, et al. 1991 The role of insulin sensitivity and hepatic lipase in dyslipidaemia of type 2 diabetes. Diabetic Med. 8:560-566.
23. Tikkanen MJ, Nikkila EA. 1987 Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J. 113:562-567.
24. Geisthovel F, Olbrich M, Frorath B, Thielmann M, Weitzell R. 1994 Obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal women. 9:610-616.
25. Robinson S, Henderson AD, Gelding SV, et al. 1996 Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf). 44:277-284.
26. Miller GJ, Koplan JP, Morgan P, et al. 1979 High density lipoprotein cholesterol concentration and other serum lipids in an isolated island community free of coronary heart disease. Int J Epidemiol. 8:219-225.
27. Hornick CA, Fellmeth BD. 1981 High density lipoprotein cholesterol, insulin and obesity in Samoans. Atherosclerosis. 39:321-328.
28. Robinson D, Ferns GA, Bevan EA, et al. 1987 High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis. 7:341-346.
29. 3 quantitative method based on precipitation with polyethylene glycol. Clin Chim Acta. 148:139-147.
30. Graf M, Richards CJ, Brown V, et al. 1990 The independent effects of hyperandrogenaemia, hyperinsulinaemia and obesity on lipid and lipoprotein profiles in women. Clin Endocrinol (Oxf). 33:119-000.
31. Rojanasakul A, Chailurkit L, Sirimongelkasim R, Chaturachinda K. 1988 Serum lipid and lipoproteins in women with polycystic ovarian disease with different body mass index. Int J Obstet Gynecol. 27:401-406.
32. Holte J, Bergh T, Berne C, Lithell H. 1944 Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf). 41:463-471.
33. Gordon DJ, Probstfield JL, Garrision, et al. 1984 High density lipoprotein cholesterol and cardiovascular disease four prospective American studies. Circulation. 79:8-15.20.
34. Kunz F, Pechlaner C, Erhart R, Fend F, Muhlberger V. 1994 HDL and plasma phospholipids in coronary artery disease. Arterioscler Thromb. 14:1146-1150.
35. Miller NE. 1987 Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. 113:589-597.
36. Kiddy DS, Hamilton-Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietery treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
37. Dennis KE, Goldberg AP. 1993 Differential effects of body fat distribution on risk factors for cardiovascular disease in women. Arterioscler Thromb. 13: 1487-1494.